SAN LEANDRO, Calif., Sept. 02, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (BTHE) (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care ...
PLEASANTON, Calif.--(BUSINESS WIRE)--DiaCarta, Ltd. (“DiaCarta”), a novel molecular diagnostic test developer for cancer and infectious diseases, today announced that the company has formed strategic ...
SAN LEANDRO, Calif., Sept. 02, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, ...
In early February 2020, Kirsten St. George and her team at New York state's public health lab received a test developed by the Centers for Disease Control and Prevention to diagnose people infected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback